University of California San Francisco

Promoting inclusion of people with HIV in clinical trials. (40690539)

Hauser JD, Leslie KS PMID: 40690539

Layilin regulates Treg motility and suppressive capacity in skin. (40690378)

Gouirand V, Clancy S, Macon C, Valle J, Pauli M, Truong HA, Cohen J, Kinet M, Lowe MM, Lord SJ, Skruber K, Harris H, Kim E, Neuhaus I, Reif K, Zarrin AA, Mullins RD, Rosenblum MD PMID: 40690378

Layilin regulates Treg motility and suppressive capacity in skin. (40690378)

Gouirand V, Clancy S, Macon C, Valle J, Pauli M, Truong HA, Cohen J, Kinet M, Lowe MM, Lord SJ, Skruber K, Harris H, Kim E, Neuhaus I, Reif K, Zarrin AA, Mullins RD, Rosenblum MD PMID: 40690378

Neurocosmetics are cosmetics, which mean that they could have effects only on skin. (40675232)

Misery L, Maibach HI, Koo J, Jafferany M PMID: 40675232

Neurocosmetics are cosmetics, which mean that they could have effects only on skin. (40675232)

Misery L, Maibach HI, Koo J, Jafferany M PMID: 40675232

Understanding Patient Priorities for Psoriatic Disease Research. (40687120)

Marquez-Grap G, Leung A, Kranyak A, Adkins K, Smith J, O'Neal A, Eakin G, Liao W PMID: 40687120

Cognitive bias in clinical large language models. (40640549)

Mahajan A, Obermeyer Z, Daneshjou R, Lester J, Powell D PMID: 40640549

Are We Reading Patch Test Reactions in a Uniform Way? An International Contact Dermatitis Research Group Study. (40631994)

Bruze M, Ale I, Andersen KE, Elsner P, Goh CL, Goossens A, Jerajani H, Maibach H, Matsunaga K, Nixon R, Sasseville D PMID: 40631994

Skin Picking in Down syndrome: A Patient Speaks Out. (40623202)

Epstein Z, Epstein L, Rork J, Koo J, Kranyak A PMID: 40623202

Phase I Trial to Evaluate the Safety of Intralesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma. (40655531)

Wang CJ, Bang A, Chowdhury S, Leslie KS, Lang UE, Shimoda M, Henrich TJ, Hoh R, Deeks SG, Wang C, Deitchman AN, Couey P, Maurer T PMID: 40655531